Interferon therapy and its association with depressive disorders – A review
Open accessThe DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Abstract
Interferons (IFNs) are important in controlling the innate immune response to viral infections. Besides that, studies have found that IFNs also have antimicrobial, antiproliferative/antitumor and immunomodulatory effects. IFNs are divided into Type I, II and III. Type I IFNs, in particular IFN-α, is an approved treatment for hepatitis C. However, patients developed neuropsychological disorders during treatment. IFN-α induces proinflammatory cytokines, indoleamine 2,3-dioxygenase (IDO), oxidative and nitrative stress that intensifies the body’s inflammatory response in the treatment of chronic inflammatory disease. The severity of the immune response is related to behavioral changes in both animal models and humans. Reactive oxygen species (ROS) is important for synaptic plasticity and long-term potentiation (LTP) in the hippocampus. However, excess ROS will generate highly reactive free radicals which may lead to neuronal damage and neurodegeneration. The limbic system regulates memory and emotional response, damage of neurons in this region is correlated with mood disorders. Due to the drawbacks of the treatment, often patients will not complete the treatment sessions, and this affects their recovery process. However, with proper management, this could be avoided. This review briefly describes the different types of IFNs and its pharmacological and clinical usages and a focus on IFN-α and its implications on depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One specific cytokine, IL-1β, activates the kynurenine pathway in human hippocampal progenitor cells and contributes to the reduction of neurogenesis.”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TNF-α, a pro-inflammatory cytokine, induces excitotoxic damage to surrounding neurons by activating microglia, which in turn promote the release of glutamate.”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent potentiation in hippocampal neurons, which are responsible for memory storage, will lead to their damage by type I interferons, leading to depressive-like behaviour [55,56].”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“TNF-α can reduce tight junction protein expression, resulting in the increase of the permeability of the blood–brain barrier (BBB) and leading to larger gaps between the endothelial cells and a consequent loss of BBB integrity.”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [55]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00363 · Cited by 1,416
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Glutamate as a neurotransmitter in the healthy brain
Zhou, Y., & Danbolt, N. C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1180-8 · Cited by 979
A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 830
Chronic stress, cognitive functioning and mental health
Marin, M.-F., Lord, C., Andrews, J., Juster, R.-P., Sindi, S., Arsenault-Lapierre, G., Fiocco, A. J., & Lupien, S. J. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.02.016 · Cited by 654
Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases
Kak, G., Raza, M., & Tiwari, B. K. (2018) · Biomolecular Concepts · doi:10.1515/bmc-2018-0007 · Cited by 617
Complex modulation of cell type-specific signaling in response to type I interferons
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.014 · Cited by 530
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Mikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M. (2021) · Brain Sciences · doi:10.3390/brainsci11101298 · Cited by 450
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity
Ank, N., Iversen, M. B., Bartholdy, C., Staeheli, P., Hartmann, R., Jensen, U. B., Dagnaes-Hansen, F., Thomsen, A. R., Chen, Z., Haugen, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2474 · Cited by 419
Sheng, J. A., Bales, N. J., Myers, S. A., Bautista, A. I., Roueinfar, M., Hale, T. M., & Handa, R. J. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.601939 · Cited by 418
Psychiatric Complications of Long-term Interferon Alfa Therapy
Renault, P. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090055011 · Cited by 413
Interferon-γ: A historical perspective
Billiau, A., & Matthys, P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.004 · Cited by 412
Felger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 391
Raison, C. L., Borisov, A. S., Majer, M., Drake, D. F., Pagnoni, G., Woolwine, B. J., Vogt, G. J., Massung, B., & Miller, A. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.010 · Cited by 367
Guarding the frontiers: the biology of type III interferons
Wack, A., Terczyńska-Dyla, E., & Hartmann, R. (2015) · Nature Immunology · doi:10.1038/ni.3212 · Cited by 364
The host type I interferon response to viral and bacterial infections
PERRY, A. K., CHEN, G., ZHENG, D., TANG, H., & CHENG, G. (2005) · Cell Research · doi:10.1038/sj.cr.7290309 · Cited by 360
Hill, M. N., & Tasker, J. G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.030 · Cited by 341
How to increase serotonin in the human brain without drugs
Young, S. N. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0738 · Cited by 335
Tavares, R. G., Tasca, C. I., Santos, C. E. S., Alves, L. B., Porciúncula, L. O., Emanuelli, T., & Souza, D. O. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00133-4 · Cited by 320
Hauser, P., Khosla, J., Aurora, H., Laurin, J., Kling, M. A., Hill, J., Gulati, M., Thornton, A. J., Schultz, R. L., Valentine, A. D., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001119 · Cited by 313
Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma
Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barral, A., Carvalho, J. S., Barral-Netto, M., Brandely, M., Silva, L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001043220104 · Cited by 310
Self-citationZheng, Z.-H., Tu, J.-L., Li, X.-H., Hua, Q., Liu, W.-Z., Liu, Y., Pan, B.-X., Hu, P., & Zhang, W.-H. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.007 · Cited by 304
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
Vanderheiden, A., Ralfs, P., Chirkova, T., Upadhyay, A. A., Zimmerman, M. G., Bedoya, S., Aoued, H., Tharp, G. M., Pellegrini, K. L., Manfredi, C., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00985-20 · Cited by 301
Type I and III interferon responses in SARS-CoV-2 infection
Kim, Y.-M., & Shin, E.-C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00592-0 · Cited by 296
Stress and the HPA Axis: Balancing Homeostasis and Fertility.
Joseph, D., & Whirledge, S. (2017) · International journal of molecular sciences · doi:10.3390/ijms18102224 · Cited by 290
Wichers, M. C., & Maes, M. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0402 · Cited by 285
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus
Bonaccorso, S., Marino, V., Biondi, M., Grimaldi, F., Ippoliti, F., & Maes, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00264-1 · Cited by 284
Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
Yang, X., Zhang, X., Fu, M. L., Weichselbaum, R. R., Gajewski, T. F., Guo, Y., & Fu, Y.-X. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.004 · Cited by 269
Sterner, E. Y., & Kalynchuk, L. E. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.005 · Cited by 260
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
Kappos, L., Traboulsee, A., Constantinescu, C., Erälinna, J. P., Forrestal, F., Jongen, P., Pollard, J., Sandberg-Wollheim, M., Sindic, C., Stubinski, B., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000237994.95410.ce · Cited by 257
Lasfar, A., Lewis-Antes, A., Smirnov, S. V., Anantha, S., Abushahba, W., Tian, B., Reuhl, K., Dickensheets, H., Sheikh, F., Donnelly, R. P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3653 · Cited by 254
Psychiatric Symptoms in Patients With Chronic Hepatitis C Receiving Interferon Alfa-2b Therapy
Kraus, M. R., Schafer, A., Faller, H., Csef, H., & Scheurlen, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0614 · Cited by 245
11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
Mechanisms of Interferon-alpha induced apoptosis in malignant cells
Thyrell, L., Erickson, S., Zhivotovsky, B., Pokrovskaja, K., Sangfelt, O., Castro, J., Einhorn, S., & Grandér, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205179 · Cited by 239
Interferon induction and function at the mucosal surface
Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2013) · Immunological Reviews · doi:10.1111/imr.12101 · Cited by 220
Dieperink, E., Ho, S. B., Thuras, P., & Willenbring, M. L. (2003) · Psychosomatics · doi:10.1176/appi.psy.44.2.104 · Cited by 218
Xaus, J., Cardó, M., Valledor, A. F., Soler, C., Lloberas, J., & Celada, A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80085-0 · Cited by 182
IFN‐α subtypes: distinct biological activities in anti‐viral therapy
Gibbert, K., Schlaak, J., Yang, D., & Dittmer, U. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12010 · Cited by 174
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis
Rossi, S., Studer, V., Motta, C., Polidoro, S., Perugini, J., Macchiarulo, G., Giovannetti, A. M., Pareja-Gutierrez, L., Calò, A., Colonna, I., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004411 · Cited by 167
Magariños, A. M., Orchinik, M., & McEwen, B. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00882-8 · Cited by 163
Kitagami, T., Yamada, K., Miura, H., Hashimoto, R., Nabeshima, T., & Ohta, T. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02776-8 · Cited by 163
Interferon-beta: Mechanism of action and dosing issues
Markowitz, C. E. (2007) · Neurology · doi:10.1212/01.wnl.0000277703.74115.d2 · Cited by 163
Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia
Pavol, M. A., Meyers, C. A., Rexer, J. L., Valentine, A. D., Mattis, P. J., & Talpaz, M. (1995) · Neurology · doi:10.1212/wnl.45.5.947 · Cited by 160
Morrow, M. P., Pankhong, P., Laddy, D. J., Schoenly, K. A., Yan, J., Cisper, N. J., & Weiner, D. B. (2009) · Blood · doi:10.1182/blood-2008-11-190520 · Cited by 152
Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why?
Groettrup, M., Khan, S., Schwarz, K., & Schmidtke, G. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01251-2 · Cited by 147
The effects of chronic mild stress on male Sprague–Dawley and Long Evans rats
Bielajew, C. H., Konkle, A. T. M., & Merali, Z. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00222-x · Cited by 146
Maes, M. H. J., Mihaylova, I., Ruyter, M. D., Kubera, M., & Bosmans, E. (2007) · PubMed · Cited by 141
Horikawa, N., Yamazaki, T., Izumi, N., & Uchihara, M. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00239-6 · Cited by 140
Wichers, M., Kenis, G., Koek, G. H., Robaeys, G., Nicolson, N. A., & Maes, M. H. J. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.09.007 · Cited by 135
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 131
Thelemann, C., Eren, R. O., Coutaz, M., Brasseit, J., Bouzourene, H., Rosa, M., Duval, A., Lavanchy, C., Mack, V., Mueller, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086844 · Cited by 125
Smith, L. M., Hensley, L. E., Geisbert, T. W., Johnson, J. C., Stossel, A., Honko, A. N., Yen, J. Y., Geisbert, J. B., Paragas, J., Fritz, E. A., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis921 · Cited by 119
Borsini, A., Cattaneo, A., Malpighi, C., Thuret, S., Harrison, N. A., MRC ImmunoPsychiatry Consortium, Zunszain, P. A., & Pariante, C. M. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx083 · Cited by 113
Interferon-α Stimulates the Hypothalamic- Pituitary-Adrenal Axis in vivo and in vitro
Gisslinger, H., Svoboda, T., Clodi, M., Gilly, B., Ludwig, H., Havelec, L., & Luger, A. (2008) · Neuroendocrinology · doi:10.1159/000126396 · Cited by 111
Pegylated interferons: chemical and clinical differences
Foster, G. R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02170.x · Cited by 110
Interferon-α as angiogenesis inhibitor: Learning from tumor models
Indraccolo, S. (2010) · Autoimmunity · doi:10.3109/08916930903510963 · Cited by 109
Rong, L., & Perelson, A. S. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i2.30 · Cited by 108
Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C
Dieperink, E., Ho, S. B., Tetrick, L., Thuras, P., Dua, K., & Willenbring, M. L. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2004.01.003 · Cited by 106
Role of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 103
Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity
Axtell, R. C., Raman, C., & Steinman, L. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8296-5 · Cited by 99
Friedman, R. M. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03055.x · Cited by 95
Yue, Y., Yuan, Y., Hou, Z., Jiang, W., Bai, F., & Zhang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075058 · Cited by 93
Schoedon, G., Troppmair, J., Adolf, G. R., Huber, C., & Niederwieser, A. (1986) · Journal of Interferon Research · doi:10.1089/jir.1986.6.697 · Cited by 84
Tunca, M., Tankurt, E., Akpınar, H., Akar, S., Hizli, N., & Gonen, O. (1997) · Rheumatology · doi:10.1093/rheumatology/36.9.1005 · Cited by 84
Interferon Beta: From Molecular Level to Therapeutic Effects
Abdolvahab, M. H., Mofrad, M. R. K., & Schellekens, H. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.06.001 · Cited by 84
Yen, J.-H. J., Kong, W., & Ganea, D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902542 · Cited by 81
Murialdo, G., Barreca, A., Nobili, F. M., Rollero, A., Timossi, G., Gianelli, M. V., Copello, F., Rodriguez, G., & POLLERI, A. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343833 · Cited by 80
Recurrence of depressive disorders after interferon-induced depression
Chiu, W.-C., Su, Y.-P., Su, K.-P., & Chen, P.-C. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.274 · Cited by 80
Tunca, M., Akar, S., Soytürk, M., Kırkalı, G., Resmi, H., Akhunlar, H., Gönen, O., Gallimore, J. R., Hawkins, P. N., & Tankurt, E. (2004) · PubMed · Cited by 77
Akbar, S., INABA, K., & Onji, M. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.516576.x · Cited by 73
IFN-λ Cancer Immunotherapy: New Kid on the Block
Lasfar, A., Gogas, H. J., Zloza, A., Kaufman, H. L., & Kirkwood, J. M. (2016) · Immunotherapy · doi:10.2217/imt-2015-0021 · Cited by 68
Todd, P. A., & Goa, K. L. (1992) · Drugs · doi:10.2165/00003495-199243010-00008 · Cited by 63
Hepgul, N., Cattaneo, A., Agarwal, K., Baraldi, S., Borsini, A., Bufalino, C., Forton, D. M., Mondelli, V., Nikkheslat, N., Lopizzo, N., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.50 · Cited by 62
McCarthy, S. D. S., Majchrzak-Kita, B., Racine, T., Kozlowski, H. N., Baker, D. P., Hoenen, T., Kobinger, G., Fish, E. N., & Branch, D. R. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004364 · Cited by 59
Baranyi, A., Meinitzer, A., Breitenecker, R. J., Amouzadeh-Ghadikolai, O., Stauber, R. E., & Rothenhäusler, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137022 · Cited by 58
Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives
Jayawickrama, G. S., Nematollahi, A., Sun, G., Gorrell, M. D., & Church, W. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-17979-7 · Cited by 58
Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever.
Tweezer‐Zaks, N., Rabinovich, E., Lidar, M., & Livneh, A. (2008) · PubMed · Cited by 56
Stress and serum cortisol levels in major depressive disorder: a cross-sectional study
G Bertollo, A., 1 Laboratory of Physiology Pharmacology and Psychopathology, G. P. I. B. S., E Grolli, R., E Plissari, M., A Gasparin, V., Quevedo, J., Z Réus, G., D Bagatini, M., M Ignácio, Z., 2 Santa Catarina State University, W. H. E. C., et al. (2020) · AIMS Neuroscience · doi:10.3934/neuroscience.2020028 · Cited by 56
Kokordelis, P., Krämer, B., Körner, C., Boesecke, C., Voigt, E., Ingiliz, P., Glässner, A., Eisenhardt, M., Wolter, F., Kaczmarek, D., et al. (2014) · Hepatology · doi:10.1002/hep.26782 · Cited by 55
Lucaciu, L., & Dumitrascu, D. L. (2015) · PubMed Central · Cited by 54
Lin, F., & Young, H. A. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.47a3002 · Cited by 54
Tsao, C.-W., Lin, Y.-S., Cheng, J.-T., Lin, C.-F., Wu, H.-T., Wu, S.-R., & Tsai, W.-H. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107082951 · Cited by 50
Alavi, M., Grebely, J., Matthews, G. V., Petoumenos, K., Yeung, B., Day, C., Lloyd, A. R., Van Beek, I., Kaldor, J. M., Hellard, M., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07035.x · Cited by 45
Vécsei, L., & Beal, M. F. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90043-h · Cited by 38
Type I IFN regulate DC turnover in vivo
Mattei, F., Bracci, L., Tough, D. F., Belardelli, F., & Schiavoni, G. (2009) · European Journal of Immunology · doi:10.1002/eji.200939233 · Cited by 37
[Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
Otsubo, T., Miyaoka, H., Kamijima, K., ONUKI, M., Ishii, M., & Mitamura, K. (1997) · PubMed · Cited by 35
Anxiogenic activity of quinolinic acid and kynurenine in the social interaction test in mice
Lapin, I. P., Mutovkina, L. G., Ryzov, I. V., & Mirzaev, S. (1996) · Journal of Psychopharmacology · doi:10.1177/026988119601000312 · Cited by 32
Antigen processing and presentation by macrophages
Allen, P. M., & Unanue, E. R. (1984) · American Journal of Anatomy · doi:10.1002/aja.1001700319 · Cited by 30
Hanson, R. W., & Owen, O. E. (2013) · Encyclopedia of Biological Chemistry · doi:10.1016/b978-0-12-378630-2.00040-2 · Cited by 27
Interferon β for rheumatoid arthritis: new clothes for an old kid on the block
Vervoordeldonk, M. J., Aalbers, C. J., & Tak, P. P. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.097899 · Cited by 25
Almeida, A. G.-D., Quarantini, L. C., Sampaio, A. S., Lyra, A. C., Parise, C. L., Paraná, R., de Oliveira, I. R., Koenen, K. C., Miranda-Scippa, Â. M. D. A., & Guindalini, C. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.06.001 · Cited by 23
Interferon Gamma Prolongs Survival of Varicella-Zoster Virus-Infected Human NeuronsIn Vitro
Baird, N. L., Bowlin, J. L., Hotz, T. J., Cohrs, R. J., & Gilden, D. (2015) · Journal of Virology · doi:10.1128/jvi.00594-15 · Cited by 22
Yang, R., Maes, H., Romanelli, M. M. C., Dellner, F., Wen, T., & Kiessling, R. W. (1998) · Cytokine · doi:10.1006/cyto.1998.0357 · Cited by 21
Resolving Familial Mediterranean Fever Attacks with Interferon Alpha
Tankurt, E., Tunca, M., Akbaylar, H., & GÖNEN, Ö. (1995) · Rheumatology · doi:10.1093/rheumatology/35.11.1188 · Cited by 19
Depression and anxiety in patients receiving interferon-alpha: The role of illness perceptions
Hepgul, N., Pariante, C. M., Baraldi, S., Borsini, A., Bufalino, C., Russell, A., Agarwal, K., Cleare, A. J., Forton, D. M., Henderson, M., et al. (2018) · Journal of Health Psychology · doi:10.1177/1359105316658967 · Cited by 19
Xu, J. H., Ji, Y., Shogren, K. L., Okuno, S. H., Yaszemski, M. J., & Maran, A. (2021) · Gene · doi:10.1016/j.gene.2021.145865 · Cited by 5
Caraceni (1998) · doi:10.1002/(sici)1097-0142(19980801)83:3
(2000) · doi:10.1002/1097-0142(20000715)89:2
Research works printed but not linked: 1
- Thau L Gandhi J Sharma S. Physiology, cortisol. Treasure Island, Florida (FL): StatPearls Publishing (2022). Available at: https://www.ncbi.nlm.nih.gov/books/NBK538239/. 30855827
Cited by
Lei, A. A., Phang, V. W. X., Lee, Y. Z., Kow, A. S. F., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072940 · Cited by 207
“Persistent potentiation in hippocampal neurons, which are responsible for memory storage, will lead to their damage by type I interferons, leading to depressive-like behaviour [55,56].”
Self-citationLiang, G., Kow, A. S. F., Yusof, R., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2024) · Biomedicines · doi:10.3390/biomedicines12010184 · Cited by 68
“Several hypotheses have been proposed regarding the underlying mechanisms of depression, including the monoamine hypothesis, neuroinflammation and oxidative damage, HPA axis abnormalities, and the neurogenesis hypothesis [2–4].”
BackgroundSelf-citationInnate immunity and interferon in SARS-CoV-2 infection outcome
Savan, R., & Gale, M. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.018 · Cited by 54
Neuroimmune modulation in liver pathophysiology
Zou, J., Li, J., Wang, X., Tang, D., & Chen, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03181-w · Cited by 45
“Interferons (IFNs), as a highly beneficial therapy in hepatitis C and B, also bring about many neuropsychological disorders such as depression, anxiety, and other symptoms that affect the patient’s quality of life [222].”
BackgroundPalepu, M. S. K., Bhalerao, H. A., Sonti, R., & Dandekar, M. P. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176960 · Cited by 39
Metadata
- Authors
- Lai, J. Y., Ho, J. X., Kow, A. S. F., Liang, G., Tham, C. L., Ho, Y.-C., & Lee, M. T.
- Affiliations
- UCSI University (MY)
- Universiti Putra Malaysia (MY)
- I-Shou University (TW)
- Corresponding author
- Ho, Yu-Cheng
- Lee, Ming Tatt
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-02-22
- Volume
- 14
- Pages
- 1048592-1048592
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9992192
- OpenAlex
- W4321498954
- Semantic Scholar
- d76ad389ebcd6bb5a9d0263eae5526170b6b1e05
- Cited by
- 46
- References
- 102
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 10 · 2023: 8
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Higher Education, Malaysia (FRGS/1/2021/WAB13/UCSI/02/1)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- interferon therapy, interferon-alpha, depressive disorders, hepatitis C treatment, neuropsychiatric adverse effects, oxidative stress, reactive oxygen species, neuroinflammation, indoleamine 2,3-dioxygenase, limbic system, medication adherence, mood disorders
- MeSH terms
- Animals, Depressive Disorder, Humans, Interferon Type I, Cytokines, Interferon-alpha, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.